Aileron Therapeutics, Inc.
PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
Last updated:
Abstract:
Methods for treating liquid cancer, determined to lack a p53 deactivation mutation, in a subject are provided. Also provided are peptidomimetic macrocycles for use in treatment of a liquid cancer, determined to lack a p53 deactivation mutation, in a subject.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2018
Issue date:
22 Aug 2019